These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 10563194)

  • 1. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
    Lai RS; Chen CC; Lee PC; Lu JY
    Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
    Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ
    Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Beinert T; Fürst H; Fink U
    Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
    Dejsomritrutai W; Senawong S; Promkiamon B
    Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].
    Riedel U; Schönfeld N; Savaser A; Serk M; Loddenkemper R
    Pneumologie; 1999 Oct; 53(10):471-6. PubMed ID: 10596548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
    Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
    Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
    Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
    Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of CYFRA 21-1 in malignant pleural fluids.
    Satoh H; Sumi M; Yagyu H; Ishikawa H; Suyama T; Naitoh T; Saitoh T; Hasegawa S
    Oncology; 1995; 52(3):211-4. PubMed ID: 7536317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
    Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
    J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.